TOTB: Pneumonia
Pneumonia remains a significant cause of morbidity and mortality worldwide, challenging clinicians with its diverse presentations and evolving management strategies. Recent advances and updated guidelines by authoritative bodies such as the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) have refined the diagnosis and treatment of community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP). Contemporary research, including pivotal studies published in leading journals like the New England Journal of Medicine and JAMA, continues to influence clinical practice by addressing key issues such as the role of corticosteroids in severe CAP, diagnostic accuracy, and antimicrobial stewardship. This post synthesizes current evidence-based recommendations and expert insights to provide a comprehensive overview of pneumonia management in adults, aiming to enhance patient outcomes through informed clinical decision-making.
